SciELO - Scientific Electronic Library Online

 
vol.19 número1Linfomas B y T: Diagnóstico inmunofenotípico de los linfomas no hodgkinianosAlteraciones de la solubilización e inhibición de la precipitación de inmunocomplejos en la anemia drepanocítica índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Cubana de Hematología, Inmunología y Hemoterapia

versão On-line ISSN 1561-2996

Resumo

SAGARRA VERANES, Martha. Synovectomy with rifampicin in haemophilic patients. Rev Cubana Hematol Inmunol Hemoter [online]. 2003, vol.19, n.1, pp. 0-0. ISSN 1561-2996.

Haemarthroses are the most frequent clinical manifestations of haemophilia. They are present in 80 and 90 % of the cases. The chronic synovitis is a serious complication due to the recurrent hemarthrosis. Different conservative treatments, such as rehabilitation and physiotherapy may be used to correct this articular alteration. If these methods fail, other techniques as surgical synovectomy and non-surgical synovectomy (chemical or isotopical) may be applied. According to the clinical pictures and the radiological results, 16 joints (10 knees, 4 ankles and 2 elbows) were treated with chemical synovectomy in 16 patients aged 7-18, 14 of them with haemophilia A and 2 with haemophilia B. The procedure consists in injecting rifampicin and intraarticular lidocaine once a week for 7 weeks at the most, covering the patient with replacement therapy up to 30 % only the day of the procedure. The indication of the synoviorthesis in more than a haemarthrosis per month allowed to obtain satisfactory results

Palavras-chave : SYNOVITIS [surgery]; SYNOVITIS [rehabilitation]; HAEMARTHROSIS [drug therapy]; PHYSICAL THERAPY TECHNIQUES; HAEMOPHILIA A [complications]; HAEMOPHILIA A [drug therapy]; HAEMOPHILIA B [complications]; HAEMOPHILIA B [drug therapy]; RIFAMPICIN [therapeutic use]; LIDOCAINE [terapeutic use].

        · resumo em Espanhol     · texto em Espanhol

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License